Jill Quigley
Direktor/Vorstandsmitglied bei TERNS PHARMACEUTICALS, INC.
Vermögen: 139 200 $ am 30.04.2024
Aktive Positionen von Jill Quigley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TERNS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.12.2020 | - |
Independent Dir/Board Member | 01.12.2020 | - | |
CHEMOMAB THERAPEUTICS LTD. | Direktor/Vorstandsmitglied | 21.06.2022 | - |
Independent Dir/Board Member | 21.06.2022 | - |
Karriereverlauf von Jill Quigley
Ehemalige bekannte Positionen von Jill Quigley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PASSAGE BIO, INC. | Geschäftsführer | 01.11.2018 | 31.12.2021 |
Nutrinia Ltd.
Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Vorstandsvorsitzender | 01.01.2016 | 01.11.2018 |
General Counsel | 01.01.2016 | 01.11.2018 | |
SHIRE | General Counsel | 01.07.2012 | 01.01.2016 |
NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.07.2012 | 01.11.2015 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Corporate Officer/Principal | 01.05.2011 | 01.07.2012 |
INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Corporate Officer/Principal | 01.11.2009 | 01.05.2011 |
Dechert LLP
Dechert LLP Miscellaneous Commercial ServicesCommercial Services Dechert LLP provides legal services. It serves the chemical, construction, finance and real estate, energy, insurance, and health sectors. The firm's practice areas include business restructuring and reorganization, commercial litigation, corporate and securities, energy, finance and real estate, financial services, mergers and acquisitions, and private equity. The company was founded in 1875 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01.03.2006 | 01.03.2009 |
Ausbildung von Jill Quigley
Rutgers Law School | Graduate Degree |
American University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Israel | 3 |
Frankreich | 2 |
Operativ
Corporate Officer/Principal | 4 |
General Counsel | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
PASSAGE BIO, INC. | Health Technology |
INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
TERNS PHARMACEUTICALS, INC. | Health Technology |
CHEMOMAB THERAPEUTICS LTD. | Health Technology |
Private Unternehmen | 5 |
---|---|
Nutrinia Ltd.
Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Dechert LLP
Dechert LLP Miscellaneous Commercial ServicesCommercial Services Dechert LLP provides legal services. It serves the chemical, construction, finance and real estate, energy, insurance, and health sectors. The firm's practice areas include business restructuring and reorganization, commercial litigation, corporate and securities, energy, finance and real estate, financial services, mergers and acquisitions, and private equity. The company was founded in 1875 and is headquartered in Philadelphia, PA. | Commercial Services |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Börse
- Insiders
- Jill Quigley
- Erfahrung